Northwest Biotherapeutics Inc
NWBO· OTC
NWBONorthwest Biotherapeutics Inc
Filed Apr 8, 2013 · 10-K · 98 days after period end · 0001144204-13-020507
derived · Computed from the longer spans the company filed.
| Metric | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|---|
| Revenue | $322.00K | $0.00 | — |
| Net Income | -$30.52M | -$12.58M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Northwest Biotherapeutics Inc · CIK 1072379 · Engraved from SEC EDGAR
ended Dec 31, 2012 · filed Apr 8, 2013 · 98 d after period end
